Chemic Laboratories Inc. and Euticals SpA Announce Renewal of Joint Cooperation Agreement

June 23, 2014

Chemic Laboratories Inc. and Euticals SpA today announced the renewal of a joint cooperation agreement that will enable the two pharmaceutical development and manufacturing firms to continue to cooperate on a variety of client engagements, primarily in the areas of Active Pharmaceutical Ingredient (API) research, development and production. Under this agreement, the companies can continue to leverage their collective expertise in pharmaceutical analytics, development and commercial manufacturing to make a definitive difference in their client’s business performance speeding the time products can be brought to market.

“Chemic continues to be excited and pleased with the working relationship with Euticals SpA, which has enjoyed a strong reputation as a global leader in the area of pharmaceutical API commercialization”, said Joseph St. Laurent, President and CSO of Chemic Laboratories Inc. This joint agreement continues to place our two firms at the forefront of the rapidly expanding marketplace of companies that are seeking to use outsource development and manufacturing expertise to support their pharmaceutical API development and commercial manufacturing activities.

“Euticals is excited about continuing our successful partnership with Chemic Laboratories and our commitment in delivering early to commercial phase pharmaceutical development services to emerging biopharmaceuticals companies. Chemic Laboratories has been successfully working with a range of embryonic and emerging biopharmaceutical companies whose success often requires large-scale and commercial solutions. The partnership with Chemic Laboratories is in line with our strategy of expanding and reinforcing our presence on the CMO market, by leveraging our extensive industrial capacity and broad spectrum on technologies,” said Margalit Fine, CEO of Euticals SpA. Euticals takes pride in reliable, regulatory compliance, and valueadded partner with our clients in providing integral development and manufacturing services.

The cooperation model between the two companies consists of Euticals scaling active pharmaceutical ingredients to commercial scale following compound development by Chemic Laboratories. This model will result in expedient and reliable supply of the highest quality API to our customers.

News & Fairs Archive

Euticals S.p.a.
- V.le Milano, 86 - 26900 Lodi | P.I. & C.F. 07254610152 | Cap. Soc. € 40.828.466,30 iv - R.E.A. 1851470 Isc. Reg. Imp. di Milano | Notice >